Condition: Rheumatoid Arthritis
Interventions: Biological: Phase 1: Etanercept; Drug: Phase 1: Methotrexate; Drug: Phase 2: Optional ETN, SSZ, HCQ, MTX; Drug: Phase 1: Methotrexate; Drug: Phase 1: Conventional DMARD
Sponsors: Pfizer; Amgen
Recruiting - verified August 2011
